Literature DB >> 3804881

Distribution of metronidazole susceptibility factors in obligate anaerobes.

S Narikawa.   

Abstract

The distribution of metronidazole susceptibility factors in clinically important bacteria was studied to determine why obligate anaerobes were susceptible to metronidazole and facultative ones were not. With obligate and facultative anaerobes, nitroreductase activity, metronidazole uptake, pyruvate:ferredoxin oxidoreductase activity and drug susceptibility were estimated. Nitroreductase activity was distributed in the obligate anaerobes and some facultative ones such as Streptococcus faecalis. Propionibacterium acnes, Bifidobacterium adolescentis, Actinomyces israelii and most of the facultative anaerobes had no such activity. Bacteria with nitroreductase activity were able to absorb the drug. Pyruvate:ferredoxin oxidoreductase activity was distributed in all of the obligate anaerobes, whereas Prop. acnes, Bif. adolescentis, A. israelii and all of the facultative anaerobes had no such activity. Distribution of metronidazole susceptibility was the same as that of pyruvate:ferredoxin oxidoreductase activity. Therefore metronidazole may selectively inhibit obligate anaerobes with pyruvate:ferredoxin oxidoreductase activity. Nitroreductase activity may be necessary for drug uptake as well.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3804881     DOI: 10.1093/jac/18.5.565

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  10 in total

Review 1.  Why metronidazole is active against both bacteria and parasites.

Authors:  J Samuelson
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

Review 2.  Susceptibility testing of anaerobic bacteria: myth, magic, or method?

Authors:  H M Wexler
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

3.  Comparison of the nucleic acids of helical and coccoid forms of Helicobacter pylori.

Authors:  S Narikawa; S Kawai; H Aoshima; O Kawamata; R Kawaguchi; K Hikiji; M Kato; S Iino; Y Mizushima
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

4.  Effects of CYP2C19, MDR1, and interleukin 1-B gene variants on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxicillin, and metronidazole.

Authors:  Barbara Gawrońska-Szklarz; Andrzej Siuda; Mateusz Kurzawski; Dariusz Bielicki; Wojciech Marlicz; Marek Droździk
Journal:  Eur J Clin Pharmacol       Date:  2010-04-08       Impact factor: 2.953

5.  Detection by PCR of the nim genes encoding 5-nitroimidazole resistance in Bacteroides spp.

Authors:  S Trinh; G Reysset
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

6.  Modulation of Iron Import and Metronidazole Resistance in Bacteroides fragilis Harboring a nimA Gene.

Authors:  Ana Paunkov; József Sóki; David Leitsch
Journal:  Front Microbiol       Date:  2022-06-09       Impact factor: 6.064

7.  Metronidazole activation and isolation of Clostridium acetobutylicum electron transport genes.

Authors:  J D Santangelo; D T Jones; D R Woods
Journal:  J Bacteriol       Date:  1991-02       Impact factor: 3.490

8.  Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis.

Authors:  Christina Y Lee; Ryan K Cheu; Melissa M Lemke; Andrew T Gustin; Michael T France; Benjamin Hampel; Andrea R Thurman; Gustavo F Doncel; Jacques Ravel; Nichole R Klatt; Kelly B Arnold
Journal:  Nat Commun       Date:  2020-12-01       Impact factor: 14.919

9.  Metronidazole enhances killing of Porphyromonas gingivalis by human PMNs.

Authors:  Mihaela Anca Serbanescu; Morvarid Oveisi; Chunxiang Sun; Noah Fine; Anne Bosy; Michael Glogauer
Journal:  Front Oral Health       Date:  2022-08-29

Review 10.  Drug Resistance in the Microaerophilic Parasite Giardia lamblia.

Authors:  David Leitsch
Journal:  Curr Trop Med Rep       Date:  2015
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.